Previous Close | 0.1900 |
Open | 0.1900 |
Bid | 0.1850 x 0 |
Ask | 0.1950 x 0 |
Day's Range | 0.1850 - 0.1900 |
52 Week Range | 0.1000 - 0.3500 |
Volume | |
Avg. Volume | 36,481 |
Market Cap | 26.997M |
Beta (5Y Monthly) | 3.06 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2100 |
Earnings Date | Aug 12, 2024 - Aug 16, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Dallas, Texas--(Newsfile Corp. - July 2, 2024) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: ...
New CFO brings a wealth of financial and capital markets expertise Vancouver, British Columbia--(Newsfile Corp. - June 26, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that Mr. Robert Peets, a seasoned strategy and finance executive, will be appointed Chief Financial Officer ("CFO") of the Company effective July 1, 2024. He ...
Vancouver, British Columbia--(Newsfile Corp. - June 26, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal year ended March 31, 2024."Fiscal 2024 was an incredible turnaround year for Burcon. We cleared a number of key milestones in our revised business plan. The Company is in an excellent position to ...